Mercia Ventures has secured a 4.5x return after exiting Gentronix as part of its sale to Danish-based Scantox Group. Gentronix is a world leader in genetic toxicology and has been acquired for an undisclosed sum. The deal provides an exit for Mercia Ventures’ Northern Venture Capital Trusts (VCTs), which have sold their stake in the … Continue reading Mercia Ventures exits Gentronix  at 4.5x return